Rothschild Redburn Starts MiniMed Group (MMED) at Buy
Rothschild Redburn analyst Issie Kirby initiates coverage on MiniMed Group (NASDAQ: MMED) with a Buy rating and a price target ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

